Hereditary nonpolyposis colorectal cancer

被引:0
|
作者
Lynch, HT [1 ]
Lynch, JF [1 ]
机构
[1] Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA
来源
SEMINARS IN SURGICAL ONCOLOGY | 2000年 / 18卷 / 04期
关键词
hereditary nonpolyposis colorectal neoplasms; adenomatous polyposis coli; incidence; germ-line mutation; microsatellite repeats; genetic counseling; genetic screening; neoplasms/etiology/genetics; genetic predisposition to disease; colorectal neoplasms/prevention and control; risk analysis; sex factors; pedigree; informed consent insurance bias; disease progression; endometrial neoplasms; ovarian neoplasms;
D O I
10.1002/(SICI)1098-2388(200006)18:4<305::AID-SSU5>3.0.CO;2-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hereditary nonpolyposis colorectal cancer (HNPCC), or Lynch syndrome, is the most common form of hereditary colorectal cancer (CRC). A well-orchestrated cancer family history is essential for its diagnosis since, unlike its familial adenomatous polyposis (FAP) hereditary cancer counterpart, HNPCC lacks distinguishing clinical stigmata of its cancer genetic risk. Discoveries in the 1990s of germ-line mutations, the most common of which are hMSH2 and hMLH1, have added enormous power to the diagnosis of Lynch syndrome. Its medical management is contingent upon its natural history. For example, approximate to 70% of CRCs occur proximal to the splenic flexure, with one-third of the cancers occurring in the cecum, thereby mandating full colonoscopy. A high rate of metachronous CRCs indicates the need for no less than a subtotal colectomy for the management of initial CRC. Genetic counseling is essential prior to DNA testing, and at the time of disclosure of the results. Education of patients as well as physicians about all facets of this disorder is extremely important. If patients are to show compliance with germ-line testing, screening, and management options, they must understand the natural history and the significance of their genetic risk status. Physicians must also be aware of clinical nuances of this disorder to provide the necessary care. Semin, Surg, Oncol. 18:305-313, 2000, (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 50 条
  • [1] Hereditary nonpolyposis colorectal cancer
    Schulmann K.
    Schmiegel W.
    [J]. Der Gastroenterologe, 2010, 5 (1): : 16 - 22
  • [2] Hereditary nonpolyposis colorectal cancer
    Frebourg, T
    Mauillon, J
    Thomas, G
    Olschwang, S
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (8-9): : 708 - 714
  • [3] Hereditary nonpolyposis colorectal cancer
    O'Reilly, S
    Johnson, KA
    Brensinger, JD
    Giardiello, FM
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (11) : 1151 - 1156
  • [4] Colorectal cancer prognosis in hereditary nonpolyposis colorectal cancer
    Watson, P
    Lin, K
    Lynch, HT
    Rodriguez-Bigas, MA
    [J]. FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 207 - 210
  • [5] HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER
    MECKLIN, JP
    SVENDSEN, LB
    PELTOMAKI, P
    VASEN, HFA
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (08) : 673 - 677
  • [6] Hereditary nonpolyposis colorectal cancer - An update
    Baba, S
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (10) : S86 - S95
  • [7] Heterogeneity in hereditary nonpolyposis colorectal cancer
    Halvarsson, Britta
    Planck, Maria
    Isinger, Anna
    Nilbert, Mef
    [J]. MODERN PATHOLOGY, 2006, 19 : 60 - 60
  • [8] Identifying hereditary nonpolyposis colorectal cancer
    Lynch, HT
    Smyrk, TC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21): : 1537 - 1538
  • [9] Pathology of hereditary nonpolyposis colorectal cancer
    Jass, JR
    [J]. COLORECTAL CANCER: NEW ASPECTS OF MOLECULAR BIOLOGY AND IMMUNOLOGY AND THEIR CLINICAL APPLICATIONS, 2000, 910 : 62 - 74
  • [10] Hereditary nonpolyposis colorectal cancer is preventable
    delaChapelle, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 979 - 979